X
Xilio Therapeutics, Inc. (XLO)
NCM – Real Time Price. Currency in USD
9.05
+0.16 (1.80%)
At close: Jun 26, 2026, 4:00 PM EDT
9.05
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
9.05
+0.16 (1.80%)
At close: Jun 26, 2026, 4:00 PM EDT
9.05
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $150.3M significantly exceed its total debt $6.6M, ensuring strong financial flexibility
Total current assets $154.2M exceed Total current liabilities $43.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$22.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.59 | 6.05 | 10 | |
| Quick ratio | 3.59 | 5.63 | 10 | |
| Debt to Equity | 0.09 | 0.30 | 9.0 | |
| Debt to Assets | 0.04 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 6M | 44M | 53M |
| Gross Profit | -2M | -2M | 5M | 42M | 52M |
| Operating Income | -89M | -79M | -60M | -42M | -42M |
| Net Income | -88M | -76M | -58M | -35M | -31M |
| EBITDA | -87M | -77M | -58M | -40M | -41M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 57.23 | 73.66 | 10 |
| Next quarter | N/A | 40.26 | 5.5 |
| Current year | -17.73 | 27.92 | 5.5 |
| Next year | -20.72 | 14.24 | 4.5 |
| Weighted average score | 6.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -7.57 | -191.97 | -171.59 | -994.07 | 1.0 |
| Y/Y | 331.67 | 28.16 | 76.98 | -179.07 | 7.8 |
| 3y average | 862.63 | 25.67 | 49 | 51.45 | 10 |
| 5y average | 917.18 | 4.67 | 55.79 | 9.15 | 7.5 |
| Weighted average score | 6.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |